Description:
The EDWARDS PRIMA PLUS STENTLESS BIOPROSTHESIS MODEL 2600P is an exceptional product by EDWARDS LIFESCIENCES LLC., dedicated to improving patient's lives. It is a tissue heart valve that is primarily used in open heart surgery for valve replacement.
The unique stentless design of the Model 2600P paves the way for a smoother and more natural blood flow, leading to improved hemodynamics. The use of this bioprosthesis can minimize the pressure gradient and potentially increase valve durability.
Using the latest research and technology, the Model 2600P is manufactured from bovine pericardial tissue treated with Edwards' proprietary ThermaFix process. This process enhances the tissue's performance and durability, reducing the potential for calcification and tissue deterioration.
Healthcare providers may benefit from fewer reoperations due to its superior durability compared to traditional heart valve implants. And for the patient, it can offer an enhanced quality of life, fewer medical complications, and an overall longer life expectancy.
Trust the EDWARDS PRIMA PLUS STENTLESS BIOPROSTHESIS MODEL 2600P for optimal heart valve performance.
Description:
The Carpentier-Edwards Bioprosthesis Models 2625 & 6625 by Edwards Lifesciences LLC are advanced, reliable heart valve replacement devices designed to improve the quality of life for patients suffering from significant valvular heart diseases.
Featuring highly durable bovine pericardial tissue, these bioprosthetic heart valves are designed specifically to emulate the natural functioning of the heart valves, thereby providing optimal haemodynamic performance with an enhanced patient safety record. The Model 2625 is primarily used for mitral valve replacement while Model 6625 is utilized for aortic valve replacement.
The Carpentier-Edwards Bioprosthesis Models are notable for their long-term durability and low thrombogenicity. Patients who have these implants typically do not require lifelong anticoagulation therapy, unlike their mechanical counterparts, which is a significant benefit and increases patients' lifestyle flexibility.
Furthermore, the Models 2625 and 6625 leverage the proven Carpentier-Edwards design, known for its exceptional reliability, backed by extensive clinical data spanning over three decades of successful use in the field of cardiac surgery. This brings an added peace of mind to both medical professionals and patients alike.
In summary, the Carpentier-Edwards Bioprosthesis Models 2625 & 6625 allow for effective heart valve replacements, elevating patient's quality of life, reducing the need for aggressive postoperative therapy, and being backed by a history of successful clinical outcomes.
... Read moreDescription:
The Carpentier-Edwards Perimount Pericardial Bioprosthesis series is a range of high-end heart valves produced by the globally recognized medical device manufacturer, Edwards Lifesciences LLC. The primary use of these devices is to replace damaged or dysfunctional aortic or mitral heart valves, thereby improving stenotic or regurgitant heart conditions.
Characterized by their robust design and cutting-edge technology, these devices boast improved hemodynamic performance contributing to enhanced patient outcomes. This series of valves features unique pericardial leaflets, which aim to simulate the action of natural heart valves, ensuring a high standard of biocompatibility and durability.
Each model within this comprehensive series has been meticulously designed and tested to cater to a wide spectrum of patients' needs. Particularly, the 2700TFX, 2800TFX, 3000TFX, and 6900X models come with a trusted ThermaFix process that preserves the pericardial tissue, enhancing its longevity.
The Carpentier-Edwards Perimount Pericardial Bioprosthesis series promises a significant advancement in cardiovascular medical devices, providing patients with a better quality of life and giving clinicians a highly reliable, state-of-the-art tool for valve replacement procedures. With these models, Edwards Lifesciences LLC continues to reaffirm its commitment to pioneering heart health technology.
... Read more